First Time Loading...

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 277 SEK -1.91% Market Closed
Updated: May 17, 2024
SOBI
/
Income Statement
/
Selling, General & Administrative

Swedish Orphan Biovitrum AB (publ)
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Swedish Orphan Biovitrum AB (publ)
Selling, General & Administrative Peer Comparison

Comparables:
BIOG B
BONEX
VITR
PROB
BIOA B

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Selling, General & Administrative
-kr6.9B
CAGR 3-Years
-20%
CAGR 5-Years
-24%
CAGR 10-Years
-27%
Biogaia AB
STO:BIOG B
Selling, General & Administrative
-kr402.5m
CAGR 3-Years
-27%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Selling, General & Administrative
-kr498.3m
CAGR 3-Years
-36%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Selling, General & Administrative
-kr1.1B
CAGR 3-Years
-51%
CAGR 5-Years
-29%
CAGR 10-Years
-20%
Probi AB
STO:PROB
Selling, General & Administrative
-kr173.7m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-20%
BioArctic AB
STO:BIOA B
Selling, General & Administrative
-kr200.3m
CAGR 3-Years
-47%
CAGR 5-Years
-29%
CAGR 10-Years
N/A

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Selling, General & Administrative?
Selling, General & Administrative
-6.9B SEK

Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Selling, General & Administrative amounts to -6.9B SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-27%

Over the last year, the Selling, General & Administrative growth was -24%. The average annual Selling, General & Administrative growth rates for Swedish Orphan Biovitrum AB (publ) have been -20% over the past three years , -24% over the past five years , and -27% over the past ten years .

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.